Zafgen Provides Update on Investigational New Drug Application for ZGN-1061
BOSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) — Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems […]
Athenex Announces Initiation of a Phase I/II Clinical Study of Oraxol in Combination with Anti-PD1
BUFFALO, N.Y., Nov. 26, 2018 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development […]
Study Supports Valeritas’ V-Go® Can Improve Glycemic Control in Type 2 Patients When Using an Easy to Follow Physician-Driven Insulin Titration Algorithm
BRIDGEWATER, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
– Primary endpoint achieved with both EPIDIOLEX doses compared to placebo – – Today’s data represents the fourth positive Phase […]
Carrefour Supply Chain Showcases GenDrive-Powered Lift Truck Fleet at Grand Opening in France
This Carrefour distribution center is home to the largest fuel cell deployment in Europe LATHAM, N.Y., Nov. 26, 2018 (GLOBE […]
Aravive Announces Participation at Upcoming Investor Conference
HOUSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that company management […]
Form 8 (DD) – Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR […]
TSX News -
Auryn Identifies Multiple Copper-Gold Drill Targets at Sombrero
VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) — Auryn Resources Inc. (TSX: AUG, NYSE AMERICAN: AUG, “Auryn” or the […]
Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter
First Quarter of Profitability for Clinic and Cannabis Product Divisions 99% of 98,000 kg Annual Cannabis Production Capacity to Come Online […]
Repeat: Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Canopy Rivers […]
